Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Looking back and to the future: Are we improving 'cure' in non-small cell lung cancer?

Thumbnail
View/Open
Supporting information (63.31Kb)
Date
2017-04
ICR Author
Walder, David
O'Brien, Mary
Marsden,
Author
Walder, D
O'Brien, M
Type
Journal Article
Metadata
Show full item record
Abstract
In surgical series, cancer-free survival at 5 years is often referred to as a cure. In recent years, attempts to improve cure rates in non-small cell lung cancer (NSCLC) have focussed on earlier diagnosis through cost-effective screening programs. Systemic therapies have historically added only a small benefit to overall survival in both the adjuvant and palliative setting. However, in the last two decades, the development of new treatment options has added incremental improvements in NSCLC survival rates. Patients with a targetable sensitising mutation including epidermal growth factor receptor gene mutations and anaplastic lymphoma kinase rearrangements have significantly better prognosis, and many will survive beyond 5 years. Immunotherapy is an effective treatment in selected patients with NSCLC and is set to cause another leap in 5 year survival rates. Although these patients are not free from disease, survival at 5 years may become the more important end-point as NSCLC becomes seen as a chronic oncological disease.
URI
https://repository.icr.ac.uk/handle/internal/1129
DOI
https://doi.org/10.1016/j.ejca.2017.01.006
Collections
  • Clinical Studies
Subject
Humans
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Antineoplastic Agents
Treatment Outcome
Immunotherapy
Forecasting
Research team
Treatment of thoracic tumours
Language
eng
Date accepted
2017-01-05
License start date
2017-04
Citation
European journal of cancer (Oxford, England : 1990), 2017, 75 pp. 192 - 194

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.